TORS ‘viable’ and preserves QoL in oropharyngeal cancer

Patients with oropharyngeal squamous cell carcinoma who are treated with transoral robotic surgery maintain a high quality of life at 1-year post-surgery, a prospective study indicates
Source: MedWire News - Oncology - Category: Cancer & Oncology Source Type: news